Non‐physiological levels of circulating cortisol in growth hormone‐treated hypopituitary adults after conventional cortisone substitution

REFERENCES

• Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP. Glucocorti-coid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 1997; 46: 255–61.
   Google Scholar
• Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA. Effect of glucocorticoid replace-ment therapy on bone mineral density in patients with Addison disease. Ann Intern Med 1994; 120: 207–10.
   PubMed Web of Science ®Google Scholar
• Orth DN, Island DP. Light synchronization of the circadian rhythm in plasma cortisol (17-0HCS) concentration in man. J Clin Endocrinol Metab 1969; 29: 479–86.
   PubMed Web of Science ®Google Scholar
• Udelsman R, Goldstein DS, Loriaux DL, Chrousos GP. Catecholamine-glucocorticoid inter-actions during surgical stress. J Surg Res 1987; 43: 539–45.
   PubMed Web of Science ®Google Scholar
• Brandenberger G, Follenius M, Wittersheim G, Salame P. Plasma catecholamines and pituitary adrenal hormones related to mental task demand under quiet and noise conditions. Biol Psychol 1980; 10: 239–52.
   PubMed Web of Science ®Google Scholar
• Cohen N, Gilbert R, Wirth A, Casley D, Jerums G. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replace-ment in Addison's disease. J Clin Endocrinol Metab 1996; 81: 1411–5.
   Google Scholar
• Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001; 86: 2909–22.
   Google Scholar
• Williams GH, Dluhy RG. Disorders of the adrenal cortex. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jamesson JL, editors. Harrison's principles of internal medicine. 15th ed. USA: McGraw Hill; 2001. p. 2099
   Google Scholar
• Melmed S. Disorders of the anterior pituitary and hypothalamus. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jamesson JL, editors. Harrison's principles of internal medicine. 15th ed. USA: McGraw Hill; 2001. p. a2034.
   Google Scholar
• Groves RW, Toms GC, Houghton BJ, Monson JP. Corticosteroid replacement therapy: twice or thrice daily? J R Soc Med 1988; 81: 514–6.
   PubMed Web of Science ®Google Scholar
• Howlett TA. An assessment of optimal hydro-cortisone replacement therapy. Clin Endocrinol (Oxf) 1997; 46: 263–8.
   PubMed Web of Science ®Google Scholar
• Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol (Oxf) 1978; 9: 571–6.
   Google Scholar
• Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) 1981; 14: 451–8.
   PubMed Web of Science ®Google Scholar
• Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR, Monson JP. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypo-pituitary adults. Clin Endocrinol (Oxf) 1994; 41: 639–48.
   Google Scholar
• Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP. The effect of growth hormone replacement therapy on corti-sol—cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogen-ase activity. Clin Endocrinol (Oxf) 1998; 48: 153–62.
   Google Scholar
• Toogood AA, Taylor NF, Shalet SM, Monson JP. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypo-pituitary patients. J Clin Endocrinol Metab 2000; 85: 1727–30.
   PubMed Web of Science ®Google Scholar
• Kehlet H, Binder C, Blichert-Toft M. Glucocorti-coid maintenance therapy following adrenalect-omy: assessment of dosage and preparation. Clin Endocrinol (Oxf) 1976; 5: 37–41.
   Google Scholar
• Jenkins JS, Sampson PA. Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J 1967; 2: 205–7.
   PubMed Web of Science ®Google Scholar
• Colbum WA, DiSanto AR, Stubbs SS, Monovich RE, DeSante KA. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a single oral administration of cortisone acetate to human subjects. J Clin Pharmacol 1980; 20: 428–36.
   Google Scholar
• Srivastava LS, Werk EE Jr, Thrasher K, Sholiton LJ, Kozera R, Nolten W, Knowles HC Jr. Plasma cortisone concentration as measured by radio-immunoassay. J Clin Endocrinol Metab 1973; 36: 937 —43.
   PubMed Web of Science ®Google Scholar
• Turner AK, Carroll CJ, Pinkus JL, Charles D, Chattoraj SC. Simultaneous competitive pro-tein binding assay for cortisol, cortisone, and prednisolone in plasma, and its clinical applica-tion. Clin Chem 1973; 19: 731–6.
   Google Scholar
• Heazelwood VJ, Galligan JP, Cannell GR, Bochner F, Mortimer RH. Plasma cortisol deliv-ery from oral cortisol and cortisone acetate: relative bioavailability. Br J Clin Pharmacol 1984; 17: 55–9.
   Google Scholar
• Trainer PJ, McHardy KC, Harvey RD, Reid IW. Urinary free cortisol in the assessment of hydro-cortisone replacement therapy. Horm Metab Res 1993; 25: 117–20.
   PubMed Web of Science ®Google Scholar
• Charmandari E. Is hydrocortisone clearance 50% slower in the evening than in the morning? J Clin Endocrinol Metab 2001; 86: 948–9.
   PubMed Web of Science ®Google Scholar
• Aanderud S, Myking OL. Plasma cortisol con-centrations after oral substitution of cortisone in the fasting and non-fasting state. Acta Med Scand 1981; 210: 157–61.
   PubMedGoogle Scholar
• Rodriguez-Amao J, Perry L, Besser GM, Ross RJ. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 1996; 45: 33–7.
   Google Scholar
• Tschop M, Lahner H, Feldmeier H, Grasberger H, Morrison KM, Janssen OE, Attanasio AF, Strasburger CJ. Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults. Eur J Endocrinol 2000; 143: 769–73.
   PubMed Web of Science ®Google Scholar
• Beentjes JA, Kerstens MN, Dullaart RP. Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate. Scand J Clin Lab Invest 2001; 61: 277–86.
   Google Scholar
• Meulenberg PM, Ross HA, Swinkels LM, Benraad TJ. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta 1987; 165: 379–85.
   PubMed Web of Science ®Google Scholar
• Weaver JU, Taylor NF, Monson JP, Wood PJ, Kelly WF. Sexual dimorphism in 11 beta hydro-xysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin Endocrinol (Oxf) 1998; 49: 13–20.
   Google Scholar
• Toogood AA, Taylor NF, Shalet SM, Monson JP. Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent. Clin Endocrinol (Oxf) 2000; 52: 61–6.
   PubMed Web of Science ®Google Scholar
• Born J, Spath-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cor-tisol on sleep in normal man. J Clin Endocrinol Metab 1989; 68: 904–11.
   PubMed Web of Science ®Google Scholar